These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38894565)

  • 41. Clinical observation on therapeutic effect of filiform fire needle for vitiligo: A retrospective study.
    Huang M; Tang L; Li X; Cai H; Li L; Wan S; Long S; Zhou X; Cao W
    Dermatol Ther; 2020 Nov; 33(6):e14415. PubMed ID: 33064363
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of the efficacy of 308-nm excimer lamp monotherapy with topical tacrolimus or clobetasol 17-propionate combination therapies in localized vitiligo.
    Bapur Erduran F; Adışen E
    Photodermatol Photoimmunol Photomed; 2016 Sep; 32(5-6):247-253. PubMed ID: 27552312
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of microneedling combined with tacrolimus versus either one alone for vitiligo treatment.
    Ebrahim HM; Albalate W
    J Cosmet Dermatol; 2020 Apr; 19(4):855-862. PubMed ID: 32030880
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects.
    Lotti T; Buggiani G; Troiano M; Assad GB; Delescluse J; De Giorgi V; Hercogova J
    Dermatol Ther; 2008 Jul; 21 Suppl 1():S20-6. PubMed ID: 18727812
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined microneedling with tacrolimus vs tacrolimus monotherapy for vitiligo treatment.
    Ebrahim HM; Elkot R; Albalate W
    J Dermatolog Treat; 2021 Dec; 32(8):999-1004. PubMed ID: 32041441
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A preliminary study of fractional CO
    Wen X; Hamblin MR; Xian Y; Li Y
    Dermatol Ther; 2019 Jan; 32(1):e12747. PubMed ID: 30238584
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Triple combination therapy of narrowband ultraviolet B, fractional carbon dioxide laser and topical bimatoprost 0.01% for non-segmental vitiligo on non-facial areas: A randomized half-body, double-blind, placebo-controlled, comparative study.
    Kanokrungsee S; Khunkhet S; Rojhirunsakool S; Thadvibun K; Sahaspot T
    Dermatol Ther; 2022 Jan; 35(1):e15198. PubMed ID: 34750933
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial.
    Lim HW; Grimes PE; Agbai O; Hamzavi I; Henderson M; Haddican M; Linkner RV; Lebwohl M
    JAMA Dermatol; 2015 Jan; 151(1):42-50. PubMed ID: 25230094
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tacrolimus (FK506) ointment combined with Nb-UVB could activate both hair follicle (HF) and dermal melanocyte precursors in vitiligo: the first histopathological and clinical study.
    Gauthier Y; Almasi-Nasrabadi M; Cario-André M; Pain C; Rakhshan A; Ghalamkarpour F
    Arch Dermatol Res; 2021 Jul; 313(5):383-388. PubMed ID: 32303824
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of interleukin-10 levels in lesions of vitiligo following treatment with topical tacrolimus.
    Taher ZA; Lauzon G; Maguiness S; Dytoc MT
    Br J Dermatol; 2009 Sep; 161(3):654-9. PubMed ID: 19438859
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The efficacy of fractional carbon dioxide laser combined with narrow-band ultraviolet B phototherapy for non-segmental vitiligo: a systematic review and meta-analysis.
    Kim WI; Kim S; Lee SH; Cho MK
    Lasers Med Sci; 2021 Feb; 36(1):165-173. PubMed ID: 32572662
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Time-kinetic study of repigmentation in vitiligo patients by tacrolimus or pimecrolimus.
    Lubaki LJ; Ghanem G; Vereecken P; Fouty E; Benammar L; Vadoud-Seyedi J; Dell'Anna ML; Briganti S; Picardo M; Heenen M
    Arch Dermatol Res; 2010 Mar; 302(2):131-7. PubMed ID: 19547993
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessing effectiveness of adding niosomal atorvastatin 1% ointment to topical calcineurin inhibitor treatment in non-segmental vitiligo.
    Zartab H; Aflatoonian M; Shamsi-Meymandi S; Pardakhty A; Isazadeh A; Firooz A; Amiri R
    J Cosmet Dermatol; 2024 Jun; 23(6):2103-2108. PubMed ID: 38348697
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A single-arm open-label clinical trial of autologous epidermal cell transplantation for stable vitiligo: A 30-month follow-up.
    Orouji Z; Bajouri A; Ghasemi M; Mohammadi P; Fallah N; Shahbazi A; Rezvani M; Vaezirad F; Khalajasadi Z; Alizadeh A; Taghiabadi E; Dashtbozorgi S; Aghdami R; Hosseini SE; Bahahrvand H; Shafieyan S; Aghdami N
    J Dermatol Sci; 2018 Jan; 89(1):52-59. PubMed ID: 29103774
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of vitiligo with narrowband-UVB (TL01) combined with tacrolimus ointment (0.1%) vs. placebo ointment, a randomized right/left double-blind comparative study.
    Nordal EJ; Guleng GE; Rönnevig JR
    J Eur Acad Dermatol Venereol; 2011 Dec; 25(12):1440-3. PubMed ID: 21466589
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Once-daily upadacitinib versus placebo in adults with extensive non-segmental vitiligo: a phase 2, multicentre, randomised, double-blind, placebo-controlled, dose-ranging study.
    Passeron T; Ezzedine K; Hamzavi I; van Geel N; Schlosser BJ; Wu X; Huang X; Soliman AM; Rosmarin D; Harris JE; Camp HS; Pandya AG
    EClinicalMedicine; 2024 Jul; 73():102655. PubMed ID: 38873632
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Different methods of enhancing the efficacy of topical tacrolimus in extra-facial vitiligo: A comparative study.
    Esmat SM; Gawdat HI; Hegazy RA; Ahmed FS; Said ER
    J Cosmet Dermatol; 2021 Nov; 20(11):3545-3551. PubMed ID: 33626213
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative study between efficacy of Excimer light with topical Tacrolimus 0.1% versus excimer light with topical Bimatoprost 0.01% in treatment of facial Vitiligo.
    Zaky MS; Atallah RB; El Abasy NTA; Elsaie ML
    Arch Dermatol Res; 2024 Jun; 316(7):350. PubMed ID: 38850408
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pimecrolimus cream in repigmentation of vitiligo.
    Seirafi H; Farnaghi F; Firooz A; Vasheghani-Farahani A; Alirezaie NS; Dowlati Y
    Dermatology; 2007; 214(3):253-9. PubMed ID: 17377388
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The efficacy of 308-nm excimer laser/light (EL) and topical agent combination therapy versus EL monotherapy for vitiligo: A systematic review and meta-analysis of randomized controlled trials (RCTs).
    Bae JM; Hong BY; Lee JH; Lee JH; Kim GM
    J Am Acad Dermatol; 2016 May; 74(5):907-15. PubMed ID: 26785803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.